acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't care if you sell or not.
I'm just stating what I expect the price to be after the shareholder's meeting when the filing is released announcing the increase in authorized shares to two billion.
I think the bottom will be in the .065 - .07 range which is only 20-25% lower than today's low which isn't that much downside considering the number of authorized shares is doubling.
As I've stated before I think my price prediction has no effect on the share price. It's only my opinion based on previous trading patterns.
I'm expecting it to bottom in the .065-.07 range following the shareholder's meeting on 9/22.
L.P.C. can buy shares for as low as .04.
If you think .10 is a good price then I suggest you act on your belief and buy some shares today.
What I believe is irrelevant to where the share price goes. Just along for the ride.
Expect the share price to hit .07 before the end of October.
L.P.C. can buy shares as low as four cents.
The following are the items for the shareholder's meeting on 9/22/2014.
Proposal(s)
Recommendations of the Board of Directors
Your Vote
1) DIRECTOR
1) GERALD E. COMMISSIONG
2) DR. JOHN W. COMMISSIONG
3) ROBERT L. HARRIS
4) DR. DAVID A. LOWE
5) DONALD D. HUFFMAN
For All Nominees
1) GERALD E. COMMISSIONG
2) DR. JOHN W. COMMISSIONG
3) ROBERT L. HARRIS
4) DR. DAVID A. LOWE
5) DONALD D. HUFFMAN
2) TO RATIFY THE APPOINTMENT OF MARCUM LLP AS THE COMPANY'S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.
For
3) TO RECOMMEND, BY NON-BINDING ADVISORY VOTE, THE APPROVAL OF THE COMPENSATION DISCLOSED IN THE PROXY STATEMENT OF THE COMPANY'S EXECUTIVE OFFICERS, WHO ARE NAMED IN THE PROXY STATEMENT COMPENSATION TABLE.
For
4) TO RECOMMEND, BY NON-BINDING VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.
1 Year
5) TO APPROVE AN AMENDMENT TO THE COMPANY'S ARTICLES OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK FROM 1,000,000,000 TO 2,000,000,000.
For
6) TO APPROVE AN AMENDMENT TO THE COMPANY'S FIRST AMENDED 2008 STOCK PLAN TO INCREASE THE NUMBER OF COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 28,242,127 TO 46,119,832.
For
7) TO APPROVE THE COMPANY'S 2014 STOCK PLAN.
For
Below .40 by Friday appears to be likely.
$AMBS - .20 P.T. - Zacks analyst, Jason Napodano, CFA,
Twitter: @JNapodano
"My Thoughts on $AMBS"
http://bionapcfa.blogspot.com/2014/09/amarantus-investor-call-highlights.html
Four Investor Conferences Scheduled:
First Annual Zacks Healthcare Meetup
September 8, 2014
16th Annual Rodman & Renshaw Healthcare Conference
September 8 - September 10, 2014
New York Palace Hotel, New York, NY
The presentation is scheduled for Tuesday, September 9th at 2:30 PM ET.
Webcast: http://wsw.com/webcast/rrshq24/ambs
Aegis Capital Healthcare and Technology Conference
September 10 - September 13, 2014
The Encore at Wynn, Las Vegas, NV
The presentation is scheduled for Thursday, September 11th at 2:30 PM PT.
Sachs Associates 14th Annual Biotech in Europe Forum
October 1, 2014 at 11:45 am
Congress Center, Basel, Switzerland
Twitter: @AmarantusBio .... 10,200 followers.
One has to wonder about the company giving Faerber an option to purchase 1,000,000 shares of stock at a price of .1235 until 7/11/24.
Don't know if this is part of a severance package or some type of hush money payment. Faerber would know where all the proverbial "financial" skeletons are buried.
In the land of penny stocks one never knows why such a gift was deemed to be a necessity.
It happens.
All IMHO.
p.s. The good news is that it could have been 5,000,000 shares at a penny a share.
It's irrelevant if anyone gives a rip or not.
I'm simply telling you where I think the share price is headed.
I think the share price will be below .09 by next Friday or sooner.
2,000,000,000 is a lot of shares.
It's great to see that Gerald is minimizing dilution and securing non-dilutive funding.
As Ripley said, "Believe It or Not".
p.s. I hope I'm wrong.
I sold 75% of my position over the last ten days.
I expect the share price will bottom in the .08 range before the end of the month after the number of authorized shares is increased to 2 billion. I don't expect any interim catalysts that would offset what will be viewed as a negative for the share price by the market.
If I'm wrong then it will be obvious.
One never knows what news might occur which could move the share price higher.
Good luck to everyone. I hope all of you make a lot of money with $AMBS.
I suggest you buy a few shares today.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
It might be a bit of a stretch but I think this makes perfect sense for anyone who is "420 friendly" and is always wondering, "where did the time go".
http://www.cowpieclocks.com
Possibly a master distributor?
If you take the time to check the two year chart for CYBK you will see that it appears to be promoted about every fourteen months.
The next cycle may begin in December of this year if it is still trading.
http://finance.yahoo.com/echarts?s=CYBK+Interactive#symbol=CYBK;range=2y
p.s. One strategy might be to average down when it goes under a penny and hope for a bounce at Christmas time. I think the company might be selling chocolate Santa Clauses.
The S.E.C. recently suspended trading in over 200 penny stocks similar to CYBK. Considering the track record of Mr. Clarke I'm surprised CYBK didn't make the list.
http://www.ag.nd.gov/NewsReleases/2012/06-21-12.pdf
Did Mr. Clarke have 40,000,000 shares to dump?
p.s. If someone owns shares in a company where the S.E.C. suspends trading can a shareholder file suit against a p.o. box?
If that is your belief then I suggest that you invest accordingly.
However, I think the current share price substantially undervalues the company as milestones are hit over the next three months.
Best of luck to you in the market.
Twitter: @AmarantusBio .... 10,200 followers.
Why do I waste my time?
Staying where we are now and moving the share price to a $1.00 would make the market cap currently at about $780M.
Doing a 1:20 reverse split and moving to the NASDAQ a share price of $15 would equate to a market cap of $585M.
$780M is achievable on the OTC market but $585 isn't achievable on the NASDAQ?
LOL!!!
p.s. Assumes current number of shares outstanding would stay at the current number which won't happen but it's irrelevant because it would have a proportionate impact under either scenario.
I hope you really don't believe what you posted.
Take my advice and buy whatever shares you can afford at the current price and hold them for three months and you'll be a happy camper.
Good luck in the market.
Twitter: @AmarantusBio .... 10,200 followers.
p.s. .30 before a 1:20 reverse split is announced. Starts trading on the NASDAQ at $7.00. $15.00 after trading on the NASDAQ for six months. Makes as much sense as any of the other speculative posts.
Note: This is my opinion.
It sucks to miss buying at the bottom.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
I was going to buy them but just as I was going to place the buy order they were gone.
It happens.
It wouldn't be the first time I was wrong and it wouldn't be the first time I was right.
Everyone is entitled to their opinion. Until it actually happens it's all just speculation.
I hope you make a tremendous amount of money with your $AMBS shares.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
Buy the dips. Nothing has changed.
LymPro partnership and O.D.D. filing for MANF for R.P. will be the key catalysts.
Share price moves above .30. 1 for 20 reverse split. Moves to the NASDAQ at $7.00. $15.00 within six months after the start of trading on the NASDAQ.
Works for me!!!
Twitter: @AmarantusBio .... 10,200 followers.
p.s. It will suck to be on the sidelines.
Key support is .103.
Place a few limit buy orders between .096 and .103 and you may get them filled tomorrow if there is no news.
I doubt if it will go below .096 unless the overall market has a significant drop.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
It's not my fault that Gerald's perception of what constitutes updates with a definitive time frame differs from mine and the market's.
I think that Gerald's failure substantially trumped my prediction. It appears that he has seen the follies of his tweeting ways and will limit the number and content of his future tweets so as to minimize having a negative impact on the share price.
So much for effectively utilizing social media to promote $AMBS. Back to "blogville".
p.s. I still own 112,000 shares.
Based on previous trading patterns when anticipated news didn't occur I would expect it to open in the .107 range tomorrow and retest .10 before the close if there is no news.
One apparent concern is that there may not be significant news between now and the conference call which is almost ten trading sessions from today.
Let's all hope that my assessment is wrong and positive news is released soon.
Twitter: @AmarantusBio .... 10,200.
p.s. This is my opinion and is not to be taken as a statement of fact.
Apparently it isn't going to happen.
It appears from Gerald's tweet today that he won't be "tweeting" quite as often in the future.
Twitter: @AmarantusBio .... 10,200 followers.
My $AMBS Crystal Ball at work.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
My $AMBS Crystal Ball:
Share price moves above .30.
1 for 20 reverse split. Moves to the NASDAQ at $7.00.
Trading at $15.00 within six months.
Catalysts: LymPro Partnership & O.D.D. filing for MANF for R.P.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
Some individuals really believed the conferences p.r. was the updates that Gerald referred to in his tweet?
LOL!!!
How do they manage to get dressed every morning?
Could hit .15 tomorrow if Gerald issues his updates.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
p.s Numerous catalysts ahead.
Share price moves above .30. 1 for 20 reverse split. Moves to the NASDAQ at $7.00. Trading at $15.00 within six months.
Works for me!!!
Twitter: @AmarantusBio .... 10,400 followers.
p.s. It will suck to be on the sidelines.
It's going to suck to be on the sidelines tomorrow.
Just saying!!!
Twitter: @AmarantusBio .... 10,200 followers.
Above .15 by Friday. Or maybe tomorrow.
Stay tuned for news from Gerald.
Twitter: @AmarantusBio .... 10,200 followers.
Watsonhelper on Yahoo:
Why the wait....
Generally, there's only one reason any company would mirror what Amarantus is doing at this point. It's strictly partnership. He is shoring up all affairs, hiring, testing, board votes, etc., it all points to one thing.
Lympro has to meet specific needs for a partner to buy in at the price they want. As part of a negotiation, AMBS is fighting by threatening RS notions, board votes to show partner they can go it alone and other strategic moves otherwise to dilute and leverage more shares to a controlling Dominion.
I believe the partner in question is getting hostile based on the moves happening, he is publicly biting back. There's a lot of correlations to make that point with Gerald changing stuff and adding more tests/corrections and more time. The FDA could are less, it's ALZ, they will approve Lympro without question and CMS will have no issues as it stands today. I also believe that someone larger came into the picture and pushed things up a notch.
None of this is bad, recognizing value is a challenging game in this arena. Think about what this is capable of fetching, even worst case scenario. The likelihood of a RS is very doubtful if they even catch a fragment of its valuation. Issuing more shares gives what to whom? Leverage...his threat to dilute to gain capital isn't about dilution, it's rather more closely synced with leverage. Hostile partners bring a lot of control over AMBS, don't think for a moment someone will come in and just give 200m without conditions. Everything he is doing is correct and strategic in nature to protect you, and what they have built.
Patience pays off in more ways than one. If he moves forward where I believe he is, this company will move mountains in speed of execution with MANF. The prospective partner has to move, he won't wait, his strategy can't allow it. I believe it all comes to a boiling point by September. BD is my 1st partner of choice, Novartis is #2 in the fight, just my opinion for the record.
Part 2:
Meant to add, why Novartis, strictly MANF. They will pay more for Lympro to gain access to controlling position on what MANF does for them in the field of Diabetes. Not saying he'll choose this route, but it's enticing from a capital stance and with Novartis' rich history of wanting MANF. Nothing worse than waiting for an incubator to get the credit it deserves. Soluble MANF has shown them a piece of the puzzle and why the need it. If you haven't looked up Soluble MANF, take a second and Google it.
Shhhhhh!!!
I need more cheap shares.
Many individuals try to mislead others by posting irrelevant comments.
I suggest everyone add a few shares at the open on Monday before Gerald's updates.
Bottom is in.
.15 by Labor Day is a lock.
Twitter: @AmarantusBio .... 10,200 followers.
p.s. I've got 112,000 shares that says it's going much higher this week.
It wouldn't surprise me to see the share price above .15 by Wednesday.
Have a great weekend!!!
Stay tuned for Gerald's updates.
Twitter: @AmarantusBio .... 10,200 followers.
p.s. Don't under estimate what the impact of a well conducted global media campaign for LymPro could have on the share price.
.15 By Next Friday
Nothing new in the 10Q. Number of shares issued in line with what was known.
The share price could be substantially higher depending on what the updates from Gerald are. The right news takes it back to .20.
LymPro partnership and up-listing moving days closer to being a reality. MANF is about due to produce substantial news as is Eltoprazine.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
Have a great weekend!!!
p.s. Amarantus hired a media manager. Why would they do that? :)
.15 By Next Friday
Nothing new in the 10Q. Number of shares issued in line with what was known.
Updates from Gerald next week.
LymPro partnership and up-listing moving days closer to being a reality.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
Have a great weekend!!!
p.s. Amarantus hired a media manager. Why would they do that?
Gerald did say there would be updates next week.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
p.s. Another day closer to a LymPro partnership and the up-listing.
$AMBS Going Forward: .30 Share Price - 1 for 20 Reverse Split Prior to the Up-Listing. Moves to the NASDAQ in the $6.50 range. 4Q2014.
Catalysts are there.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.